These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11522670)

  • 1. The generalized aminoaciduria seen in patients with hepatocyte nuclear factor-1alpha mutations is a feature of all patients with diabetes and is associated with glucosuria.
    Bingham C; Ellard S; Nicholls AJ; Pennock CA; Allen J; James AJ; Satchell SC; Salzmann MB; Hattersley AT
    Diabetes; 2001 Sep; 50(9):2047-52. PubMed ID: 11522670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1alpha (HNF-1alpha) gene.
    Menzel R; Kaisaki PJ; Rjasanowski I; Heinke P; Kerner W; Menzel S
    Diabet Med; 1998 Oct; 15(10):816-20. PubMed ID: 9796880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting diabetes phenotypes associated with hepatocyte nuclear factor-1alpha and -1beta mutations.
    Pearson ER; Badman MK; Lockwood CR; Clark PM; Ellard S; Bingham C; Hattersley AT
    Diabetes Care; 2004 May; 27(5):1102-7. PubMed ID: 15111528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-cell dysfunction, insulin sensitivity, and glycosuria precede diabetes in hepatocyte nuclear factor-1alpha mutation carriers.
    Stride A; Ellard S; Clark P; Shakespeare L; Salzmann M; Shepherd M; Hattersley AT
    Diabetes Care; 2005 Jul; 28(7):1751-6. PubMed ID: 15983330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels.
    Richter S; Shih DQ; Pearson ER; Wolfrum C; Fajans SS; Hattersley AT; Stoffel M
    Diabetes; 2003 Dec; 52(12):2989-95. PubMed ID: 14633861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variants in the hepatocyte nuclear factor-1alpha and -4alpha genes in Finnish and Chinese subjects with late-onset type 2 diabetes.
    Rissanen J; Wang H; Miettinen R; Kärkkäinen P; Kekäläinen P; Mykkänen L; Kuusisto J; Karhapää P; Niskanen L; Uusitupa M; Laakso M
    Diabetes Care; 2000 Oct; 23(10):1533-8. PubMed ID: 11023148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.
    Pearson ER; Velho G; Clark P; Stride A; Shepherd M; Frayling TM; Bulman MP; Ellard S; Froguel P; Hattersley AT
    Diabetes; 2001 Feb; 50 Suppl 1():S101-7. PubMed ID: 11272165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum amino acids in patients with mutations in the hepatocyte nuclear factor-1 alpha gene.
    Stride A; Pearson ER; Brown A; Gooding K; Castleden HA; Hattersley AT
    Diabet Med; 2004 Aug; 21(8):928-30. PubMed ID: 15270800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the hepatocyte nuclear factor-1alpha gene in Caucasian families originally classified as having Type I diabetes.
    Møller AM; Dalgaard LT; Pociot F; Nerup J; Hansen T; Pedersen O
    Diabetologia; 1998 Dec; 41(12):1528-31. PubMed ID: 9867222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased glibenclamide uptake in hepatocytes of hepatocyte nuclear factor-1alpha-deficient mice: a mechanism for hypersensitivity to sulfonylurea therapy in patients with maturity-onset diabetes of the young, type 3 (MODY3).
    Boileau P; Wolfrum C; Shih DQ; Yang TA; Wolkoff AW; Stoffel M
    Diabetes; 2002 Dec; 51 Suppl 3():S343-8. PubMed ID: 12475773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors.
    Frayling TM; Evans JC; Bulman MP; Pearson E; Allen L; Owen K; Bingham C; Hannemann M; Shepherd M; Ellard S; Hattersley AT
    Diabetes; 2001 Feb; 50 Suppl 1():S94-100. PubMed ID: 11272211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three new mutations in the hepatocyte nuclear factor-1alpha gene in Japanese subjects with diabetes mellitus: clinical features and functional characterization.
    Yoshiuchi I; Yamagata K; Yang Q; Iwahashi H; Okita K; Yamamoto K; Oue T; Imagawa A; Hamaguchi T; Yamasaki T; Horikawa Y; Satoh T; Nakajima H; Miyazaki J; Higashiyama S; Miyagawa J; Namba M; Hanafusa T; Matsuzawa Y
    Diabetologia; 1999 May; 42(5):621-6. PubMed ID: 10333057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and functional analysis of mutations in the hepatocyte nuclear factor-1alpha gene in anti-islet autoantibody-negative Japanese patients with type 1 diabetes.
    Kawasaki E; Sera Y; Yamakawa K; Abe T; Ozaki M; Uotani S; Ohtsu N; Takino H; Yamasaki H; Yamaguchi Y; Matsuura N; Eguchi K
    J Clin Endocrinol Metab; 2000 Jan; 85(1):331-5. PubMed ID: 10634407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4.
    Kaisaki PJ; Menzel S; Lindner T; Oda N; Rjasanowski I; Sahm J; Meincke G; Schulze J; Schmechel H; Petzold C; Ledermann HM; Sachse G; Boriraj VV; Menzel R; Kerner W; Turner RC; Yamagata K; Bell GI
    Diabetes; 1997 Mar; 46(3):528-35. PubMed ID: 9032114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1alpha is dominant negative.
    Yamagata K; Yang Q; Yamamoto K; Iwahashi H; Miyagawa J; Okita K; Yoshiuchi I; Miyazaki J; Noguchi T; Nakajima H; Namba M; Hanafusa T; Matsuzawa Y
    Diabetes; 1998 Aug; 47(8):1231-5. PubMed ID: 9703322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice.
    Pontoglio M; Sreenan S; Roe M; Pugh W; Ostrega D; Doyen A; Pick AJ; Baldwin A; Velho G; Froguel P; Levisetti M; Bonner-Weir S; Bell GI; Yaniv M; Polonsky KS
    J Clin Invest; 1998 May; 101(10):2215-22. PubMed ID: 9593777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes.
    Pearson ER; Liddell WG; Shepherd M; Corrall RJ; Hattersley AT
    Diabet Med; 2000 Jul; 17(7):543-5. PubMed ID: 10972586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of 1,5-anhydroglucitol measurements in patients with hepatocyte nuclear factor-1alpha maturity-onset diabetes of the young.
    Skupien J; Gorczynska-Kosiorz S; Klupa T; Wanic K; Button EA; Sieradzki J; Malecki MT
    Diabetes Care; 2008 Aug; 31(8):1496-501. PubMed ID: 18492944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetics of diabetes mellitus in Chinese subjects: identification of mutations in glucokinase and hepatocyte nuclear factor-1alpha genes in patients with early-onset type 2 diabetes mellitus/MODY.
    Ng MC; Cockburn BN; Lindner TH; Yeung VT; Chow CC; So WY; Li JK; Lo YM; Lee ZS; Cockram CS; Critchley JA; Bell GI; Chan JC
    Diabet Med; 1999 Nov; 16(11):956-63. PubMed ID: 10588527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations.
    Bellanné-Chantelot C; Chauveau D; Gautier JF; Dubois-Laforgue D; Clauin S; Beaufils S; Wilhelm JM; Boitard C; Noël LH; Velho G; Timsit J
    Ann Intern Med; 2004 Apr; 140(7):510-7. PubMed ID: 15068978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.